Boston Scientific (BSX) Total Non-Current Liabilities (2009 - 2026)
Boston Scientific (BSX) posted quarterly Total Non-Current Liabilities of $42.7 billion for Q2 2026, up 9.09% year-over-year from $39.2 billion in Q2 2025, and up 2.04% on a QoQ basis from $41.9 billion in Q1 2026.
Boston Scientific (BSX) Total Non-Current Liabilities (2009 - 2026) Analysis & Trends
Boston Scientific has reported Total Non-Current Liabilities for 18 years, with the latest figure at $42.7 billion in Q2 2026.
- Total Non-Current Liabilities for Q2 2026 came in at $42.7 billion, up 9.09% year-over-year; the trailing twelve-month figure through Jun 2026 was $42.7 billion (up 9.09% YoY), and the FY2025 annual result was $41.3 billion, up 9.97% from the prior year.
- Total Non-Current Liabilities improved to $42.7 billion in Q2 2026, from $41.9 billion in the prior quarter.
- Over five years, Total Non-Current Liabilities peaked at $42.7 billion in Q2 2026 and troughed at $30.0 billion in Q3 2022.
- A 5-year average of $35.4 billion and a median of $35.0 billion in 2024 frame the typical range for Total Non-Current Liabilities.
- The widest annual swing landed in 2022, when Total Non-Current Liabilities gained 1.42%; it then climbed 13.13% in 2024.
- A 5-year view of Total Non-Current Liabilities shows it stood at $30.4 billion in 2022, then rose by 8.99% to $33.2 billion in 2023, then increased by 13.13% to $37.5 billion in 2024, then grew by 9.97% to $41.3 billion in 2025, then grew by 3.56% to $42.7 billion in 2026.
- Per Business Quant data, the three most recent Total Non-Current Liabilities figures were $42.7 billion in Q2 2026, $41.9 billion in Q1 2026, and $41.3 billion in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.20 Bn | 194.60 Bn | 7.27 Bn | - |
| 2 | Stryker | 129.69 Bn | 126.21 Bn | 4.50 Bn | 21.28 Bn |
| 3 | Medtronic | 120.14 Bn | 110.92 Bn | 6.41 Bn | 40.90 Bn |
| 4 | Boston Scientific | 74.16 Bn | 73.62 Bn | 3.85 Bn | 42.74 Bn |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.43 Bn | 1.35 Bn | 2.57 Bn |
| 6 | Dexcom | 34.57 Bn | 32.62 Bn | 830.00 Mn | 3.68 Bn |
| 7 | GE HealthCare Technologies | 34.09 Bn | 31.98 Bn | 2.18 Bn | 23.89 Bn |
| 8 | Koninklijke Philips | 26.49 Bn | 23.17 Bn | 4.55 Bn | 9.07 Bn |
| 9 | Steris | 23.19 Bn | 22.70 Bn | 684.20 Mn | 3.44 Bn |
| 10 | Zimmer Biomet Holdings | 19.36 Bn | 18.95 Bn | 1.54 Bn | 9.53 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 42.74 Bn |
| Mar 31, 2026 | 41.88 Bn |
| Dec 31, 2025 | 41.27 Bn |
| Sep 30, 2025 | 40.32 Bn |
| Jun 30, 2025 | 39.18 Bn |
| Mar 31, 2025 | 38.19 Bn |
| Dec 31, 2024 | 37.53 Bn |
| Sep 30, 2024 | 36.24 Bn |
| Jun 30, 2024 | 35.31 Bn |
| Mar 31, 2024 | 34.75 Bn |
| Dec 31, 2023 | 33.17 Bn |
| Sep 30, 2023 | 32.19 Bn |
| Jun 30, 2023 | 31.68 Bn |
| Mar 31, 2023 | 30.90 Bn |
| Dec 31, 2022 | 30.43 Bn |
| Sep 30, 2022 | 30.03 Bn |
| Jun 30, 2022 | 30.20 Bn |
| Mar 31, 2022 | 30.34 Bn |
| Dec 31, 2021 | 30.01 Bn |
| Sep 30, 2021 | 29.58 Bn |